9 | Rituximab (Mabthera)FDA Link
01/2023
-
08/2007 |
7 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
-
12/2013 |
6 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2024
-
12/2013 |
5 | Vincristine (Oncovin)FDA LinkGeneric
12/2018
-
12/2013 |
4 | Prednisone (Sone)FDA LinkGeneric
12/2018
-
12/2013 |
3 | Chimeric Antigen ReceptorsIBA
05/2024
-
01/2020 |
3 | VaccinesIBA
09/2023
-
05/2006 |
3 | Etoposide (VP 16)FDA LinkGeneric
12/2018
-
05/2015 |
2 | ibrutinibIBA
01/2023
-
11/2018 |
2 | Monoclonal AntibodiesIBA
01/2022
-
02/2007 |
2 | Dacarbazine (DIC)FDA LinkGeneric
01/2020
-
04/2014 |
2 | Biomarkers (Surrogate Marker)IBA
01/2020
-
12/2015 |
2 | CytokinesIBA
01/2020
-
12/2013 |
2 | Bleomycin (Blenoxane)FDA LinkGeneric
01/2020
-
04/2014 |
2 | Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018
-
12/2013 |
2 | Methotrexate (Mexate)FDA LinkGeneric
01/2018
-
12/2013 |
2 | PanobinostatIBA
01/2018
-
12/2013 |
2 | Dexamethasone (Maxidex)FDA LinkGeneric
01/2018
-
12/2013 |
2 | AntigensIBA
09/2013
-
05/2006 |
2 | GemcitabineFDA Link
10/2011
-
02/2008 |
1 | RNA (Ribonucleic Acid)IBA
05/2024 |
1 | axicabtagene ciloleucelIBA
05/2024 |
1 | Lenalidomide (CC 5013)FDA Link
01/2023 |
1 | UbiquitinIBA
01/2022 |
1 | Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022 |
1 | Interleukin-6 (Interleukin 6)IBA
01/2020 |
1 | pembrolizumabIBA
01/2020 |
1 | venetoclaxIBA
01/2020 |
1 | Vinblastine (Vinblastine Sulfate)FDA Link
01/2020 |
1 | acalabrutinibIBA
01/2020 |
1 | Agammaglobulinaemia Tyrosine KinaseIBA
01/2020 |
1 | IfosfamideFDA LinkGeneric
01/2018 |
1 | Bortezomib (Velcade)FDA Link
01/2018 |
1 | IceIBA
01/2018 |
1 | Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2018 |
1 | Thyroxine (Levothyroxine)FDA LinkGeneric
01/2018 |
1 | Carboplatin (JM8)FDA LinkGeneric
01/2018 |
1 | Texas redIBA
01/2017 |
1 | Dihydrotachysterol (AT 10)IBA
01/2017 |
1 | MelatoninIBA
01/2017 |
1 | MK 2206IBA
11/2015 |
1 | EverolimusFDA Link
12/2013 |
1 | LigandsIBA
09/2013 |
1 | HLA-A*02:01 antigenIBA
09/2013 |
1 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
11/2012 |
1 | Janus Kinase 2IBA
11/2012 |
1 | coltuximab ravtansineIBA
08/2012 |
1 | Immunoconjugates (Immunoconjugate)IBA
08/2012 |
1 | Histone Deacetylase InhibitorsIBA
12/2011 |
1 | mocetinostatIBA
12/2011 |
1 | Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2011 |
1 | Yttrium-90IBA
11/2009 |
1 | ibritumomab tiuxetan (Zevalin)FDA Link
11/2009 |
1 | denileukin diftitox (Ontak)FDA Link
08/2007 |
1 | Cancer VaccinesIBA
02/2007 |
1 | IpilimumabIBA
02/2007 |
1 | PolyethyleneimineIBA
07/2006 |